BCAL Diagnostics Limited (AU:BDX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
BCAL Diagnostics Limited has announced the issuance of 9,150,000 performance rights as part of an employee incentive scheme. These securities are unquoted and intended for internal use to motivate and retain talent within the company. This move reflects BCAL’s commitment to aligning employee interests with corporate growth objectives.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.